Liquid and Gel Platelet Rich Plasma as Skin Healing Adjuvant

Tuane Nerissa Alves Garcez, Helena Flores Mello, Priscilla Domingues Mörschbacher, Paula Barros Terraciano, Viviam Pignone, Marta Justina Cioato, Elizabeth Obino Cirne-Lima, Emerson Antonio Contesini


Background: In recent decades, many researches have been conducted on processes involved in tissue repairing, mainly in the development of resources and technology designed to improve the wound healing progress. Platelet rich plasma (PRP) derived from autologous blood is defined as a plasma volume with platelet concentration higher than physiological level. It is an autogenous and low cost source of growth factors, which are essential for tissue regeneration due to their angiogenic, mitogenic, and chemotactic properties. The aim of this study was evaluate two forms of PRP- liquid and gel - regarding their capacity to influence quality and repair time of standardized skin injuries.

Materials, Methods & Results: New Zealand healthy rabbits were distributed in three groups (n = 6): control group (CG), liquid platelet rich plasma group (LIQPRP), and gel platelet rich plasma group (GELPRP). Acute skin lesions were inducted in two areas approximately 2 cm close to scapular edge and depth including epidermis, dermis, and hypodermis to external muscular fascia. Animals received treatment according to each group. Injuries were measured with digital pachymeter in two directions: longer length (l) and longer width (w), every two days. Areas and healing rates were calculated. Microscopic analysis samples were collected on days seven and 14 and evaluated through hematoxylin and eosin staining (HE) for global tissue examination, and through Masson’s trichrome (MT) to collagen fibers present within the interstice. These analyzes considered: angiogenesis, inflammation infiltrated and collagen fibers quantity. Immunohistochemistry with anti-Ki-67 antibody was utilized for proliferative profile assessment. Kruskal-Wallis’ non-parametric tests of independent samples was performed for comparison of values obtained through platelet count, referring to evaluation of platelet increase on treatments. Scar contraction rate (CR) was evaluated through Shapiro-Wilk’s normality test, and then submitted to mixed models test. Results obtained by histopathological and immunohistochemistry were also evaluated by Shapiro-Wilk’s normality test (for all tests a 5% level of significance was considered). Platelet concentration achieved with liquid PRP was 8.64 and gel PRP reached 5.62 times higher than physiological values. Platelet increase mean for both groups was 7.95. No statistical significance was observed between groups. No side-effects or adverse reactions related to PRP usage were observed while study was conducted.

Discussion: In the present study, there was a need to raise platelet poor plasma volume in order to obtain autogenous thrombin required for gel PRP. After this modification, a stable and reasonable platelet concentration gel was produced. However, this form of PRP application requires more time for sample preparation, increasing the production cost. Furthermore, injection of liquid PRP directly in the wound site activates platelets by generated substances due to needle perforation, and mainly due to tissue trauma generated at the lesion site. Relating to the therapies administered, gel PRP was considered more manageable, since 3D structure could easily adapt to wound site after simply deposition of it. Liquid PRP was administered with needle and syringe, which required the surgeon to be more careful and perform a slow injection in order to avoid any spill and loss of material. Furthermore, histopathological analysis did not point any clot traces formed by gel PRP dehydration, although it is not possible to ensure that the clot was eliminated, reabsorbed, or even removed by the animal. By this protocol, a stable and reasonable platelet concentration gel was produced. Further studies are encouraged as well as employment of alternative diagnostic tools, in order to better understand found results.


skin; regenerative therapy; cell therapy; growing factors; platelets.

Full Text:



Anitua E. 1999. Plasma rich in growth factors: preliminary results of use in the preparation or future sites for implants. International Journal of Oral Maxillofacial Implant. 14(4): 529-535.

Anitua E., Sanchez M., Nurden A., Nurden P., Orive G. & Andia I. 2006. New insights into and novel applications for platelet-rich fibrin therapies. Trends in Biotechnology. 24(5): 227-234.

Barroso C., Benito J. & Puig A. 2007. Calidad del plasma rico en plaquetas: estúdio de la activación plaquetaria. Revista Española de Cirurgía Oral y Maxilofacial. 29(4): 240-248.

Eppley B., Woodell J. & Higgins J. 2004. Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implication for Wound Healing. Plastic and Reconstructive Surgery. 114(6): 1502-1508.

Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B. & Rodeo S.A. 2009. Platelet rich plasma: from basic science to clinical applications. American Journal of Sports Medicine. 37(11): 2259-2272.

Garcez T.N.A., Paz A.H.R., Magrisso A.B., Mello F., Gonçalves F.C., Meyer F.S., Contesini E.A. & Cirne-Lima E.O. 2013. Comparison of Three Protocols to Obtain Platelet Rich Plasma (PRP) with Rabbits as Experimental Model. Acta ScientiaeVeterinariae. 41(1134): 1-7.

Hossein K., Sardari K., Emami M., Movassaghi A., Goli A., Lotfi A. & Malekzadeh S. 2008. Efficacy of Autologous Platelet-Rich Plasma (PRP) Activated by Thromboplastin-D on the Repair and Regeneration of Wounds in Dogs. Iranian Journal of Veterinary Surgery. 3(4): 19-29.

Kazakos K., Lyras D., Verettas D., Tilkeridis K. & Tryfonidis M. 2009. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. (40): 801-805.

Kevy S. & Jacobson M. 2004. Comparison of methods for point of care preparation of autologous platelet gel. Journal of Extra-Corpor Technology. 36(1): 28-35.

Landsberg R., Roy M. & Glickman R. 2000. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. Journal of Oral and Maxillofacial Surgery. 58(1): 297-300.

Lopez J., Chimenos E., Sanchez J. & Castañeda P. 2007. Plasma rico en factores de crecimiento y regeneración ósea. Dentum. 7(3): 108-112.

Maia L., Souza M., Ribeiro J., Oliveira A., Alves G., Benjamin L., Silva Y., Zandim B. & Moreira J. 2009. Plateletrich plasma in the treatment of induced tendinopathy in horses: histologic evaluation. Journal of Equine Veterinary Science. 29(8): 618-626.

Marx E. 2001. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry. 10(4): 225-228.

Monteiro B.S., Argolo-Neto N.M. & Del Carlo R.J. 2010. Células-tronco mesenquimais. Ciência Rural. 40(1): 238245.

Rebar A., MacWilliamns P., Feldman B. & Frebar A. 2003. Plaquetas. In: Guia de hematologia para cães e gatos. São Paulo: Roca, pp.131-156.

Santoso S. 2003. Human platelet alloantigens. Transfusion and Apheresis Science. (28): 227-236.

Silva A. 2007. Plasma rico em plaquetas (PRP) associado ou não ao osso esponjoso autógeno no reparo de falhas ósseas experimentais. 32f. (Dissertação Mestrado Curso de Pós-graduação em Medicina Veterinária, Universidade Federal de Viçosa.

Vendramin F.S., Franco D., Nogueira C.M., Pereira M.S. & Franco T.R. 2006. Plas¬ma rico em plaquetas e fatores de crescimento: técnica de obtenção e utilização em cirurgia plástica. Revista do Colégio Brasileiro de Cirurgiões. 33(1): 24-28.

Vendramin F.S., Franco D. & Franco R. 2009. Método de obtenção do gel de plasma rico em plaquetas autólogo. Revista Brasileira de Cirurgia Plástica. 24(2): 212-218.

Vendrúsculo P. 2012. Avaliação da eficácia de diferentes protocolos de preparo do Plasma Rico em Plaquetas para uso em Medicina Equina. Pesquisa Veterinária Brasileira. 32(2): 106-110.

Webrich G., Hansen T. & Kleis G. 2004. Effect of platelet concentration in platelet rich plasma on peri-implant bone regeneration. Bone. 34(4): 665-671.


Copyright (c) 2018 Tuane Nerissa Alves Garcez, Helena Flores Mello, Priscilla Domingues Mörschbacher, Paula Barros Terraciano, Viviam Pignone, Marta Justina Cioato, Elizabeth Obino Cirne-Lima, Emerson Antonio Contesini

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.